The first umbilical cord blood stem cell transplant was successfully performed in 1988. Since then, research has been continuously developing and offers more and more treatment opportunities.
Testimonial from Prof. Christian Breymann
FMH Gynaecology and Obstetrics
FMH Perinatal Medicine
It appears that stem cells from the umbilical cord blood as well as the umbilical cord tissue are particularly suitable for use in regenerative medicine.
Even today, bone tissue, skin tissue, nerve tissue and heart tissue can be regenerated by stem cells.
Personally, I am convinced of the great potential and possibilities of perinatal stem cells.
An additional chance of being cured
Progress of science over the last years has made it possible to envisage new therapeutic applications, especially in the following fields:
- neurology and neurosurgery
- autoimmune and metabolic diseases
Research and treatable diseases
It is difficult to draw the line between what is already a concrete therapeutic opportunity and how likely it will be in the very near future.
Today, umbilical cord stem cells offer a possibility of treatment – often the only one – for patients suffering from severe diseases, especially when it comes to blood, but not only. For the future, it is envisaged that stem cells will be able to find a solution for a large number of very severe and diffuse diseases.
Dr Giuseppe Citterio testifies
FMH Paediatrician and neonatologist,
certified Swiss Board member
“Let’s hope that in the future the public will be more sensitive about this so that more and more parents are opting for the conservation of their baby’s stem cells.”